J9056 HCPCS code: Injection, bendamustine hydrochloride (vivimusta), 1 mg
J9056 is the HCPCS Level II code for injection, bendamustine hydrochloride (vivimusta), 1 mg. In 2024 Medicare paid an average of $24.45 per service for J9056 across 300,567 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 360 per day on outpatient hospital claims. Medicare volume rose 416% from 2023 to 2024 (58,289 to 300,567 services). In 2024, about 306 clinicians billed Medicare for J9056 for 291 beneficiaries; California, Nevada, Arkansas accounted for 49% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2025-01-01 |
Who bills J9056 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 306 |
| Medicare beneficiaries | 291 |
| States with claims | 9 |
| Share of services in top 3 states (California, Nevada, Arkansas) | 49% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9056, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 58,289 | 86 | $32.67 | $26.03 |
| 2024 | 300,567 | 291 | $30.69 | $24.45 |
States with the most J9056 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 35,795 | $24.97 |
| Nevada | 31,182 | $24.68 |
| Arkansas | 24,027 | $23.38 |
| Nebraska | 23,153 | $24.64 |
| Illinois | 22,680 | $23.92 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 360 | Prescribing Information |
| practitioner claims | 360 | Prescribing Information |
What changed for J9056
- 2023-07-01: J9056 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9056?
J9056 is the HCPCS Level II code for injection, bendamustine hydrochloride (vivimusta), 1 mg. Short descriptor: "Inj, vivimusta, 1 mg".
How much does Medicare pay for J9056?
In 2024, the average Medicare payment was $24.45 per service (average allowed $30.69).
Does Medicare cover J9056?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9056 can be billed per day?
360 on outpatient hospital claims; 360 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9003 — Leuprolide injectable (camcevi etm), 1 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9056
- Watch J9056 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9056
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.